Toxicology News and Research

Latest Toxicology News and Research

Lead exposure in early childhood increases risk for sleep problems in later childhood

A new research study from the University of Pennsylvania School of Nursing shows that lead exposure in early childhood are associated with increased risk for sleep problems and excessive daytime sleepiness in later childhood.

13 Nov 2015

New computational method helps predict adverse drug reaction better than traditional computing methods

A new integrated computational method helps predicting adverse drug reaction--which are often lethal--more reliably than with traditional computing methods. This improved ability to foresee the possible adverse effects of drugs may entail saving many lives in the future.

4 Nov 2015

Pittcon will exhibit at the Bioconference clinical diagnostics and research virtual conference

Pittcon is pleased to announce its participation in the “Clinical Diagnostics & Research” virtual conference from November 11 to 12, 2015. Clinicians, researchers, medical experts, and professionals from around the world convene for this free web-conference to learn and interact with a community of like-minded colleagues.

From Pittcon 27 Oct 2015

Lower doses of chemicals found in personal care products may contribute to breast cancer risk

Estrogen-mimicking chemicals called parabens, which are commonly found in an array of personal care products, may be more dangerous at lower doses than previously thought, according to a new study.

27 Oct 2015

Orange pigment may have potential as anti-cancer drug

An orange pigment found in lichens and rhubarb called parietin may have potential as an anti-cancer drug, scientists at Winship Cancer Institute of Emory University have discovered.

20 Oct 2015

Nanodiamonds may improve outcomes for patients undergoing root canals

People undergoing root canals may have gained a powerful, if tiny, new ally. Researchers from the UCLA School of Dentistry have found that using nanodiamonds to fortify a material used in the procedure could significantly improve outcomes for patients.

19 Oct 2015

New research shows nicotine increases codeine-induced analgesia

According to new research in rat models, nicotine use over time increases the speed that codeine is converted into morphine within the brain, by increasing the amount of a specific enzyme. It appears smokers' brains are being primed for a bigger buzz from this common pain killer - which could put them at a higher risk for addiction, and possibly even overdose.

19 Oct 2015

Sense oligonucleotide antidote reverses actions of antisense antithrombotic drug, prevents bleeding

Researchers from Isis Pharmaceuticals (Carlsbad, CA) and Prysis Biotechnologies (Pudong, Shanghai, China) have demonstrated proof-of-concept for using a sense oligonucleotide to undo the effects of an antisense drug, an antithrombotic agent in this novel study.

14 Oct 2015

Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

Based on its recent analysis of the use of customer relationship management (CRM) solutions in the $70 billion US diagnostic laboratory market, Frost & Sullivan recognizes hc1.com with its 2015 North American Award for Product Leadership.

13 Oct 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan Pharmaceuticals, Inc. today announced the presentation of data from a preclinical study evaluating KTN0158 in dogs with spontaneous mast cell tumors. KTN0158 is a proprietary, humanized anti-KIT IgG1 monoclonal antibody drug candidate being developed as a potential therapy for cancer and mast cell-related diseases.

28 Sep 2015

Study reports use of new psychoactive drugs in US nationally representative survey

In recent years, there has been an increase in emergence and use of a variety of new drugs, so-called "novel psychoactive substances" (NPS) in the US and worldwide.

16 Sep 2015

Cerilliant offers first-ever multi-component solutions for qualitative evaluation of drug interference

Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.

15 Sep 2015

Inhibition of Tyk2 enzyme promotes anti-cancer activity

Tyrosine kinase 2 (Tyk2) is an enzyme involved in intracellular signalling and has an important role in activating the immune system.

11 Sep 2015

Researchers take new line of approach to combat Alzheimer's disease

Today, more than 5.1 million Americans live with Alzheimer's disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. Moreover, according to a 2012 survey, Americans fear Alzheimer's more than any other disease.

10 Sep 2015

Pre-birth arsenic exposure associated with early puberty, obesity in mice

Female mice exposed in utero, or in the womb, to low levels of arsenic through drinking water displayed signs of early puberty and became obese as adults, according to scientists from the National Institutes of Health.

27 Aug 2015

Energy-burning 'good' fat helps reduce weight gain, lower blood glucose levels in mice

Scientists at the University of California, Berkeley, have developed a novel way to engineer the growth and expansion of energy-burning "good" fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.

20 Aug 2015

Penn State College of Medicine students to work with medical educators to design new curriculum

The medical school model that has existed for decades involves two years of study in the basic sciences followed by two years of clinical study. An initiative under way at Penn State College of Medicine will involve students in developing a new curriculum that integrates the two areas of study, with a goal of preparing physicians for the new realities of health care.

20 Aug 2015

Palatin applauds FDA's approval of flibanserin for women living with hypoactive sexual desire disorder

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential. Palatin's lead product under development is bremelanotide for the treatment of female sexual dysfunction (FSD).

19 Aug 2015

NanoViricides speeds up HerpeCide drug development program

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, reports that it is accelerating its HerpeCide drug development program.

17 Aug 2015

Scientists partner to create liver-on-chip device that mimics human physiology

Safety evaluation is a critical part of drug and cosmetic development. In recent years there is a growing understanding that animal experiments fail to predict the human response, necessitating the development of alternative models to predict drug toxicity.

17 Aug 2015

Toxicology News and Research

Latest Toxicology News and Research

Lead exposure in early childhood increases risk for sleep problems in later childhood

New computational method helps predict adverse drug reaction better than traditional computing methods

Pittcon will exhibit at the Bioconference clinical diagnostics and research virtual conference

Lower doses of chemicals found in personal care products may contribute to breast cancer risk

Orange pigment may have potential as anti-cancer drug

Nanodiamonds may improve outcomes for patients undergoing root canals

New research shows nicotine increases codeine-induced analgesia

Sense oligonucleotide antidote reverses actions of antisense antithrombotic drug, prevents bleeding

Frost & Sullivan recognizes hc1.com with 2015 North American Award for Product Leadership

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Study reports use of new psychoactive drugs in US nationally representative survey

Cerilliant offers first-ever multi-component solutions for qualitative evaluation of drug interference

Inhibition of Tyk2 enzyme promotes anti-cancer activity

Researchers take new line of approach to combat Alzheimer's disease

Pre-birth arsenic exposure associated with early puberty, obesity in mice

Energy-burning 'good' fat helps reduce weight gain, lower blood glucose levels in mice

Penn State College of Medicine students to work with medical educators to design new curriculum

Palatin applauds FDA's approval of flibanserin for women living with hypoactive sexual desire disorder

NanoViricides speeds up HerpeCide drug development program

Scientists partner to create liver-on-chip device that mimics human physiology

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Toxicology News and Research

Latest Toxicology News and Research

Forensics and toxicology - Industry Focus eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in